The Exciting Potential of CAR T Cells for Multiple Myeloma Treatment with a Carefully Designed Strategy to Boost Results and Mitigate Safety Concerns. Dr. Hermann Einsele, MD and Dr. Michael Hudecek, MD, University of Würzburg, Germany
CAR T cell therapies are an exceptionally exciting non-transplant therapy future option for blood cancer patients, including multiple myeloma. CAR T cells
Posted by
HealthTree